We’ve developed a portfolio of multiplexed, multi-omic technologies to help you decode the immune response to infectious diseases, including SARS-CoV-2.
Let us help you make a difference in understanding COVID-19.
NEW! Panels Now Available.
NanoString's nCounter gene expression assays can now be used to interrogate immune response in relation to a number of pathogens and infectious diseases, including SARS-CoV-2, the virus responsible for COVID-19. Newly released panels studying Host Response and Immune Exhaustion explore the dynamic response that shapes COVID-19 progression. Any of the immunology gene expression panels can be paired with the COVID-19 spike in or Tissue Reference gene list for a targeted and impactful assay.
For a limited time only: 15% off your next NanoString project with Canopy Biosciences. Now through the end of the year, use promo code NS15.
ChipCytometry is a high-plex, quantitative imaging platform with single cell resolution. Quickly identify and visualize immune cell populations and subpopulations, and gate cells using flow cytometry-like data analyses.
RNA-Seq allows for the rapid identification of changes in gene expression across the entire exome. Profile immune disruptions due to the SARs-CoV-2 virus, identify novel biomarkers to aid in infectious disease research and more.
We've partnered with OnRamp Bio to offer their ROSALIND platform for NanoString and RNA Seq data analysis. This expanded bioinformatics platform has added several COVID-19 databases for annotation and pathway analysis specific to this pathogen.